97 related articles for article (PubMed ID: 10978654)
21. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
22. Histaminergic activation of the hypothalamic-pituitary-adrenal axis.
Kjaer A; Larsen PJ; Knigge U; Warberg J
Endocrinology; 1994 Sep; 135(3):1171-7. PubMed ID: 8070360
[TBL] [Abstract][Full Text] [Related]
23. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
Takemura T; Makino S; Takao T; Asaba K; Suemaru S; Hashimoto K
Brain Res; 1997 Sep; 767(2):181-91. PubMed ID: 9367246
[TBL] [Abstract][Full Text] [Related]
24. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
Kent P; Anisman H; Merali Z
Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
[TBL] [Abstract][Full Text] [Related]
25. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
Owens MJ; Edwards E; Nemeroff CB
Eur J Pharmacol; 1990 Nov; 190(1-2):113-22. PubMed ID: 1963847
[TBL] [Abstract][Full Text] [Related]
26. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
27. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
[TBL] [Abstract][Full Text] [Related]
28. The hypothalamo-pituitary-adrenal axis response to experimental traumatic brain injury.
Grundy PL; Harbuz MS; Jessop DS; Lightman SL; Sharples PM
J Neurotrauma; 2001 Dec; 18(12):1373-81. PubMed ID: 11780867
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin tetrapeptide effects on HPA axis function and elevated plus maze behaviour in maternally separated and handled rats.
Greisen MH; Bolwig TG; Wörtwein G
Behav Brain Res; 2005 Jun; 161(2):204-12. PubMed ID: 15922046
[TBL] [Abstract][Full Text] [Related]
30. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
Kakui N; Kitamura K
Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
[TBL] [Abstract][Full Text] [Related]
31. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment.
Stout SC; Owens MJ; Nemeroff CB
J Pharmacol Exp Ther; 2002 Mar; 300(3):1085-92. PubMed ID: 11861819
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress.
Harbuz MS; Rees RG; Eckland D; Jessop DS; Brewerton D; Lightman SL
Endocrinology; 1992 Mar; 130(3):1394-400. PubMed ID: 1537299
[TBL] [Abstract][Full Text] [Related]
33. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts.
Lee S; Barbanel G; Rivier C
Brain Res; 1995 Dec; 705(1-2):136-48. PubMed ID: 8821744
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
[TBL] [Abstract][Full Text] [Related]
35. The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation.
Harbuz MS; Stephanou A; Sarlis N; Lightman SL
J Endocrinol; 1992 Jun; 133(3):349-55. PubMed ID: 1319453
[TBL] [Abstract][Full Text] [Related]
36. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses.
Lee S; Selvage D; Hansen K; Rivier C
Endocrinology; 2004 Oct; 145(10):4470-9. PubMed ID: 15205375
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
[TBL] [Abstract][Full Text] [Related]
38. Activation of the hypothalamic-pituitary axis in adrenalectomised rats: potentiation by chronic stress.
Martí O; Harbuz MS; Andrés R; Lightman SL; Armario A
Brain Res; 1999 Mar; 821(1):1-7. PubMed ID: 10064781
[TBL] [Abstract][Full Text] [Related]
39. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
Schwartz MW; Strack AM; Dallman MF
Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
[TBL] [Abstract][Full Text] [Related]
40. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
